615 related articles for article (PubMed ID: 23673211)
21. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
Zhang L; Cen L; Qu S; Wei L; Mo M; Feng J; Sun C; Xiao Y; Luo Q; Li S; Yang X; Xu P
PLoS One; 2016; 11(4):e0152931. PubMed ID: 27045591
[TBL] [Abstract][Full Text] [Related]
22. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
23. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
[No Abstract] [Full Text] [Related]
24. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway.
Liu S; Wang Q; Liu Y; Xia ZY
J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502580
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of selenomethionine on carcinogenesis in the model of human colorectal cancer in vitro and its link to the Wnt/β-catenin pathway.
Korbut E; Ptak-Belowska A; Brzozowski T
Acta Biochim Pol; 2018; 65(3):359-366. PubMed ID: 30016378
[TBL] [Abstract][Full Text] [Related]
26. The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line.
Jin C; Song P; Pang J
Oncol Lett; 2019 Oct; 18(4):3845-3856. PubMed ID: 31579410
[TBL] [Abstract][Full Text] [Related]
27. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
29. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
30. [Injury of human gastric epithelial GES-1 cells by MNNG and its effects on Wnt/β-catenin signaling pathway].
Yan ZP; Xu TT; An ZT; Hu Y; Chen WZ; Zhu FS
Sheng Li Xue Bao; 2018 Jun; 70(3):262-268. PubMed ID: 29926067
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
Shi SL; Zhang ZH
Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529
[TBL] [Abstract][Full Text] [Related]
32. MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3β/β-catenin pathway.
Dong ZC; Zhang D; Zhang XX; Yao ZQ; Wu H; Chen CH; Tian JQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5682-5690. PubMed ID: 31298320
[TBL] [Abstract][Full Text] [Related]
33. Anti-apoptotic brain and reproductive organ-expressed proteins enhance cisplatin resistance in lung cancer cells via the protein kinase B signaling pathway.
Li Y; Qi K; Zu L; Wang M; Wang Y; Zhou Q
Thorac Cancer; 2016 Mar; 7(2):190-8. PubMed ID: 27042221
[TBL] [Abstract][Full Text] [Related]
34. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
[TBL] [Abstract][Full Text] [Related]
35. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer.
Zheng CH; Wang JB; Lin MQ; Zhang PY; Liu LC; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM
J Exp Clin Cancer Res; 2018 Mar; 37(1):59. PubMed ID: 29540196
[TBL] [Abstract][Full Text] [Related]
36. Hypoxic postconditioning activates the Wnt/β-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3β inactivation.
Zhan L; Liu D; Wen H; Hu J; Pang T; Sun W; Xu E
FASEB J; 2019 Aug; 33(8):9291-9307. PubMed ID: 31120770
[TBL] [Abstract][Full Text] [Related]
37. The suppressive effect of soluble Klotho on fibroblastic growth factor 23 synthesis in UMR-106 osteoblast-like cells.
Ma L; Gao M; Wu L; Zhao X; Mao H; Xing C
Cell Biol Int; 2018 Sep; 42(9):1270-1274. PubMed ID: 29851201
[TBL] [Abstract][Full Text] [Related]
38. MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β-catenin signaling pathway.
Wang Q; Geng F; Zhou H; Chen Y; Du J; Zhang X; Song D; Zhao H
Oncol Lett; 2019 Oct; 18(4):4294-4307. PubMed ID: 31579066
[TBL] [Abstract][Full Text] [Related]
39. GSK-3β regulates tumor growth and angiogenesis in human glioma cells.
Zhao P; Li Q; Shi Z; Li C; Wang L; Liu X; Jiang C; Qian X; You Y; Liu N; Liu LZ; Ding L; Jiang BH
Oncotarget; 2015 Oct; 6(31):31901-15. PubMed ID: 26388612
[TBL] [Abstract][Full Text] [Related]
40. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
Wei RJ; Zhang CH; Yang WZ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
